About Amar Safdar
This author has not written his bio yet.
But we are proud to say that Amar Safdar contributed 294 entries already.
Entries by Amar Safdar
Torres JA, Teperman J, Dubrovskaya Y, Press R & Safdar A. Procalcitonin (PCT) Trends as Predictor for Hospital Mortality and Improved Infection Diagnosis Compared with C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) in Cancer and Transplant Population and Patients in Critical Care Units. (Abstract # D-182) 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology (ASM). Washington, DC, September 5–9, 2014
/in Research Presentations/by Amar SafdarPenziner S, Dubrovskaya Y, Press R & Safdar A. Fidaxomicin (Fdx) Therapy in Critically Ill Patients with Clostridium difficile Infection (CDI). 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology (ASM). Washington, DC, September 5–9, 2014
/in Research Presentations/by Amar SafdarTeperman J, Torres JA, Dubrovskaya Y, Tobias H, Press R, Teperman L & Safdar A. Feasibility of Procalcitonin in Recipients of Liver, Kidney and Hematopoietic Stem Cell Transplantation: A Novel Tool in Diagnosis for Bacterial Sepsis and Respiratory Tract Infection. 2nd World Transplant Congress (WTC), a joint meeting of the American Society of Transplant Surgeons (ASTS), The Transplantation Society (TTS) and the American Society of Transplantation (AST). San Francisco, CA July 26–31, 2014
/in Research Presentations/by Amar SafdarTorres Isasiga J, Teperman J, Dubrovskaya Y, Press R, & Safdar A. Procalcitonin in Patients with Cancer: Role of Biomarker-Assisted Diagnosis for Bacterial Infections, SIRS and Sepsis Syndrome. (eP310) The 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Barcelona, Spain May 10-13, 2014
/in Research Presentations/by Amar SafdarClutter DS, Dubrovakaya Y, Merl M, Press R, Safdar A. Response to Therapy in Solid-Organ (SOT) and Hematopoietic Stem Cell Transplant (HSCT) Recipients with 61 Episodes of Clostridium difficile Infection (CDI). 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology (ASM). Denver, Colorado September 10-13, 2013
/in Research Presentations/by Amar SafdarSafdar A, Tulliano G, Taimur S, Press R. Changing Trends in Clinical Fungal Isolates at a Comprehensive University Hospital in New York City during the Past 12 Years. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology (ASM), Denver Colorado September 10-13, 2013
/in Research Presentations/by Amar SafdarSafdar A, Tulliano G, Teperman L & Press R. Enterococcal Colonization and Disease in Solid-Organ versus Hematologic Malignancy and Hematopoietic Stem Cell Transplantation Units (2000–2011). [Poster #B1053]. American Transplant Congress (ATC) at the Washington State Convention Center, Seattle, Washington May 18-22, 2013.
/in Research Presentations/by Amar SafdarDubrovskaya Y, Clutter DS, Merl M, Zain J, Teperman L, Press R & Safdar A. Fidaxomicin in the Treatment of Clostridium difficile Associated Diarrhea (CDAD) in Transplant Recipients. (Section 113: Infections in Transplant Recipients and Patients with Malignancies). The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology (ASM). San Francisco, California September 9-12, 2012
/in Research Presentations/by Amar SafdarCenter For Infectious Diseases & Immunology
6560 Fannin St
Houston, TX 77030
(713) 485-0064
amar.safdar@CIDImmunology.com
Opening Hours
Mo-Fr: 8:00am-5:00pm